All In Biotech

Drug Trial Radar · NCT06928142

A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

83

Actual

Start

Apr 23, 2025

Primary completion

Mar 13, 2027

Study completion Jun 4, 2027

Sponsor

Sponsor type
Industry
First posted
Apr 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 2 study to evaluate the effects of sibeprenlimab 400 mg administered subcutaneously (SC) every 4 (Q4) weeks as an add-on to background treatment in participants with Sjögren's disease.

Conditions

  • Sjogren Disease

Interventions

  • SibeprenlimabBiological

    400 mg administered SC Q4 weeks

  • PlaceboOther

    Administered SC Q4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (ESSDAI) scoreTime frame: 28 weeks

Locations

63 sites in 8 countries. Site status is shown where the registry gives one.

  • Medvin Clinical Research - Riverside

    Riverside, California

  • Medvin Clinical Research - Tujunga

    Tujunga, California

  • Bay Area Arthritis and Osteoporosis

    Brandon, Florida

  • Clinical Research of West Florida Inc

    Clearwater, Florida

  • GNP Research - Florida

    Cooper City, Florida

  • Vantage Clinical Trials - Tampa - ClinEdge - PPDS

    Tampa, Florida

  • OrthoIllinois, LTD

    Rockford, Illinois

  • Arnold Arthritis and Rheumatology

    Skokie, Illinois

  • Ochsner Clinic Foundation

    Baton Rouge, Louisiana

  • Albuquerque Center for Rheumatology

    Albuquerque, New Mexico

  • Bradenton Research Center Inc

    The Bronx, New York

  • DJL Clinical Research PLLC

    Charlotte, North Carolina

  • STAT Research

    Vandalia, Ohio

  • Allen Arthritis

    Allen, Texas

  • Tekton Research, LLC

    Austin, Texas

  • Advanced Rheumatology of Houston

    Houston, Texas

  • Accurate Clinical Research - Houston

    Houston, Texas

  • Accurate Clinical Management, LLC

    Katy, Texas

  • R & H Clinical Research

    Katy, Texas

  • DOM Centro de Reumatología

    Buenos Aires, Argentina

  • Expertia S.A- Mautalén Salud e Investigación

    Buenos Aires, Argentina

  • Maffei Centro Médico

    Buenos Aires, Argentina

  • Aprillus Asistencia e Investigacion de Arcis Salud SRL

    Buenos Aires, Argentina

  • Centro Polivalente de Asistencia e Investigación Clínica - CER San Juan

    San Juan, Argentina

  • Consultorios Médicos Dr. Doreski - Fundacion Respirar - PPDS

    Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

  • Instituto CER S.A.

    Quilmes, Buenos Aires, Argentina

  • Instituto Médico de la Fundación Estudios Clínicos

    Rosario, Santa Fe Province, Argentina

  • Clínica Mayo de U.M.C.B. S.R.L

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Centro de Investigaciones Médicas Tucumán - PPDS

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Medical Center Medconsult Pleven OOD

    Pleven, Bulgaria

  • University Multiprofile Hospital for Active Treatment Sveti Georgi EAD-15 A Vassil Aprilov Boulevard

    Plovdiv, Bulgaria

  • Medical Center Excelsior OOD - PPDS

    Sofia, Bulgaria

  • Diagnostic- Consultative Center Convex EOOD

    Sofia, Bulgaria

  • Medical Center- Nova Clinic

    Varna, Bulgaria

  • Mvz Rheumatologie Und Autoimmunmedizin Hamburg Gmbh

    Hamburg, Germany

  • Medicover München Ost MVZ

    München, Germany

  • Universitätsklinikum Freiburg

    Freiburg im Breisgau, Baden-Wurttemberg, Germany

  • Universitätsklinikum Köln

    Cologne, North Rhine-Westphalia, Germany

  • Olympion General Clinic

    Pátrai, Achaïa, Greece

  • Laiko General Hospital of Athens (Site 1)

    Athens, Attica, Greece

Showing 40 of 63 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.